-
1
-
-
33747790601
-
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
-
Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006;55:1255-62.
-
(2006)
Gut
, vol.55
, pp. 1255-1262
-
-
Ogata, H.1
Matsui, T.2
Nakamura, M.3
-
2
-
-
0032447773
-
Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus
-
Fellermann K, Ludwig D, Stahl M, et al. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus. Am J Gastroenterol 1998;93:1860-6.
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 1860-1866
-
-
Fellermann, K.1
Ludwig, D.2
Stahl, M.3
-
3
-
-
0036743048
-
Response of refractory colitis to intravenous or oral tacrolimus (FK506)
-
Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002;8:317-24.
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 317-324
-
-
Fellermann, K.1
Tanko, Z.2
Herrlinger, K.R.3
-
4
-
-
0038620355
-
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease
-
Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003;17:1273-81.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 1273-1281
-
-
Baumgart, D.C.1
Wiedenmann, B.2
Dignass, A.U.3
-
5
-
-
29244457275
-
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
-
Ardizzone S, Maconi G, Russo A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53.
-
(2006)
Gut
, vol.55
, pp. 47-53
-
-
Ardizzone, S.1
Maconi, G.2
Russo, A.3
-
6
-
-
0028292007
-
Cyclosporine in severe ulcerative colitis refractory to steroid therapy
-
Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
-
(1994)
N Engl J Med
, vol.330
, pp. 1841-1845
-
-
Lichtiger, S.1
Present, D.H.2
Kornbluth, A.3
-
7
-
-
0035045816
-
Intravenous cyclopsorine versus intravenous corticosteroids as single therapy of severe attacks of ulcerative colitis
-
D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclopsorine versus intravenous corticosteroids as single therapy of severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.
-
(2001)
Gastroenterology
, vol.120
, pp. 1323-1329
-
-
D'Haens, G.1
Lemmens, L.2
Geboes, K.3
-
8
-
-
10744231879
-
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis
-
van Assche G, D'Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31.
-
(2003)
Gastroenterology
, vol.125
, pp. 1025-1031
-
-
Van Assche, G.1
D'Haens, G.2
Noman, M.3
-
9
-
-
0032201035
-
Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial
-
Actis GC, Aimo G, Priolo G, et al. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis 1998;4:276-9.
-
(1998)
Inflamm Bowel Dis
, vol.4
, pp. 276-279
-
-
Actis, G.C.1
Aimo, G.2
Priolo, G.3
-
10
-
-
0030482294
-
Intravenous cyclosporine in attacks of ulcerative colitis
-
Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis. Dig Dis Sci 1996;41:2471-6.
-
(1996)
Dig Dis Sci
, vol.41
, pp. 2471-2476
-
-
Carbonnel, F.1
Boruchowicz, A.2
Duclos, B.3
-
11
-
-
0030015532
-
Predicting outcome in severe ulcerative colitis
-
Travis SPL, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10.
-
(1996)
Gut
, vol.38
, pp. 905-910
-
-
Travis, S.P.L.1
Farrant, J.M.2
Ricketts, C.3
-
12
-
-
1542619846
-
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis
-
Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004;10:73-8.
-
(2004)
Inflamm Bowel Dis
, vol.10
, pp. 73-78
-
-
Arts, J.1
D'Haens, G.2
Zeegers, M.3
-
13
-
-
12344329448
-
Ciclosporin use in acute ulcerative colitis: A long-term experience
-
Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol 2005;17:79-84.
-
(2005)
Eur J Gastroenterol Hepatol
, vol.17
, pp. 79-84
-
-
Campbell, S.1
Travis, S.2
Jewell, D.3
-
14
-
-
0033070414
-
A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin
-
Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999;5:1-10.
-
(1999)
Inflamm Bowel Dis
, vol.5
, pp. 1-10
-
-
Cohen, R.D.1
Brodsky, A.L.2
Hanauer, S.B.3
-
15
-
-
0001902429
-
A critical review of cyclosporine therapy in inflammatory bowel disease
-
Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995;1:48-63.
-
(1995)
Inflamm Bowel Dis
, vol.1
, pp. 48-63
-
-
Sandborn, W.J.1
-
16
-
-
0038460945
-
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomised controlled trial
-
Probert CS, Hearing SD, Schreiber S, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut 2003;52:998-1002.
-
(2003)
Gut
, vol.52
, pp. 998-1002
-
-
Probert, C.S.1
Hearing, S.D.2
Schreiber, S.3
-
17
-
-
20444479336
-
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study
-
Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005;128:1805-11.
-
(2005)
Gastroenterology
, vol.128
, pp. 1805-1811
-
-
Jarnerot, G.1
Hertervig, E.2
Friis-Liby, I.3
-
18
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76.
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
-
19
-
-
0347991877
-
The safety profile of infliximab in patients with Crohn's disease: The Mayo clinic experience in 500 patients
-
Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004;126:19-31.
-
(2004)
Gastroenterology
, vol.126
, pp. 19-31
-
-
Colombel, J.F.1
Loftus Jr., E.V.2
Tremaine, W.J.3
-
20
-
-
2442696315
-
Infliximab in inflammatory bowel disease: Clinical outcome in a population based cohort from Stockholm County
-
Ljung T, Karlen P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 2004;53:849-53.
-
(2004)
Gut
, vol.53
, pp. 849-853
-
-
Ljung, T.1
Karlen, P.2
Schmidt, D.3
-
21
-
-
0037372956
-
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease
-
Stallmach A, Wittig BM, Moser C, et al. Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut 2003;52:377-82.
-
(2003)
Gut
, vol.52
, pp. 377-382
-
-
Stallmach, A.1
Wittig, B.M.2
Moser, C.3
-
22
-
-
0038115119
-
Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy
-
Prajapati DN, Knox JF, Emmons J, et al. Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. J Clin Gastroenterol 2003;37:125-8.
-
(2003)
J Clin Gastroenterol
, vol.37
, pp. 125-128
-
-
Prajapati, D.N.1
Knox, J.F.2
Emmons, J.3
-
23
-
-
0033950428
-
Mycophenolate mofetil: Lack of efficacy in chronic active inflammatory bowel disease
-
Fellermann K, Steffen M, Stein J, et al. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:171-6.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 171-176
-
-
Fellermann, K.1
Steffen, M.2
Stein, J.3
-
24
-
-
0034064823
-
Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: A 12-month pilot study
-
Orth T, Peters M, Schlaak JF, et al. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study. Am J Gastroenterol 2000;95:1201-7.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1201-1207
-
-
Orth, T.1
Peters, M.2
Schlaak, J.F.3
-
25
-
-
0033003888
-
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
-
Neurath MF, Wanitschke R, Peters M, et al. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 1999;44:625-8.
-
(1999)
Gut
, vol.44
, pp. 625-628
-
-
Neurath, M.F.1
Wanitschke, R.2
Peters, M.3
|